Your Source for BioScience Venture Capital Data
  • SEARCH THE OnBioVC DATABASE:

  • OnBioVC NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • Photobucket

  • FDA Registered Contract Manufacturer

Roka BioScience (Warren, NJ) a development-stage diagnostic company focused on molecular assays for monitoring food safety applications and biopharmaceutical manufacturing, closed a $27.5M Series D financing. Participants include Aisling Capital, OrbiMed, New Enterprise Associates and TPG Biotech.

Elevation Pharmaceuticals (San Diego, CA) a clinical-stage biopharmaceutical company focused on nebulized solutions for chronic obstructive pulmonary disease and asthma, closed a $30M Series B financing. Participants include Novo Ventures, Canaan Partners, TPG Biotech, Care Capital and Mesa Verde Venture Partners.

DNAnexus (Mountain View, CA) a commercial-stage device company focused on DNA data management and analysis, closed a $15M Series B financing. Participants include Google Ventures, TPG Biotech, First Round Capital, SoftTech VC, K9 Ventures and Felicis Ventures.

Elevation Pharmaceuticals (San Diego, CA) a clinical-stage biopharmaceutical company focused on aerosol therapies for respiratory disease and COPD, closed a $17M Series A financing. Participants include Canaan Partners, Care Capital, TPG Biotech and Mesa Verde Venture Partners.

NovaSom (Glen Burnie, MD) a commercial-stage medical device company focused on the diagnosis of obstructive sleep apnea, closed a $35M Series F financing. Participants include Safeguard Scientifics, TPG Biotech and Quaker BioVentures.

Ultragenyx Pharmaceutical (Novato, CA) a clinical-stage pharmaceutical company focused on inclusion body myopathy and other rare metabolic disease,vclosed a $45M Series A financing. Participants include TPG Biotech, Fidelity Biosciences, HealthCap and Pappas Ventures.

Genomatica (San Diego, CA) a development-stage biofuel company focused on chemical intermediates derived from renewable feedstock without additional processing steps, closed a $45M Series D financing. Participants include VantagePoint Venture Partners, TPG Biotech, Mohr Davidow Ventures, Alloy Ventures, Bright Capital, Waste Management and Draper Fisher Jurvetson.

Otonomy (San Diego, CA) a clinical-stage biopharmaceutical company focused on, hearing and balance disorders such as Ménière’s disease, hearing loss, and tinnitus. closed a $38.5M Series B financing. Participants include Novo Ventures, RiverVest Venture Partners, Domain Associates and TPG Biotech.

FoldRx Pharmaceuticals (Cambridge) a clinical-stage small molecule company focused on protein misfolding and aggregation in transthyretin amyloid polyneuropathy and other neurodegenerative and cardiovascular diseases, closed a $29M Series C financing. Participants include Novo Ventures, Morgenthaler Ventures, HealthCare Ventures, Fidelity Biosciences, TPG Biotech, Alta Partners and Novartis Venture Funds.

Veracyte (San Francisco, CA) a clinical-stage molecular diagnostics company focused on non-small cell lung cancer and thyroid cancers, closed a $28M Series B financing. Participants include Domain Associates, Kleiner Perkins Caufield & Byers, TPG Biotech and Versant Ventures.

CardioDx (Palo Alto, CA) a commercial-stage cardiovascular molecular diagnostics company focused on coronary artery disease, cardiac arrhythmia and heart failure, closed a $5M Series D financing, bring the total round to $34.5M. Participants include GE Healthymagination Fund, Kleiner Perkins Caufield & Byers, TPG Biotech, Intel Capital, Mohr Davidow Ventures, DAG Ventures, Pappas Ventures and Asset [...]

Genomatica (San Diego, CA) a development-stage biofuel company focused on methods for adaptive evolution of microbes to achieve optimal performance under process conditions to produce industrial chemicals from carbohydrates, closed a $15M Series C financing. Participants include TPG Biotech, Mohr Davidow Ventures, Alloy Ventures and Draper Fisher Jurvetson.

Tandem Diabetes Care (San Diego, CA) a development-stage medical device company focused on insulin pump technology, closed a $30.8M Series C financing, bringing the total round to $52.3M. Participants include HLM Venture Partners, Domain Associates, TPG Biotech, Delphi Ventures and Kearny Venture Partners.

  

to top of page...